These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case-control study. Yokomichi H; Tanaka-Taya K; Koshida R; Nakano T; Yasui Y; Mori M; Ando Y; Morino S; Okuno H; Satoh H; Arai S; Mochizuki M; Yamagata Z Int J Hematol; 2020 Jul; 112(1):105-114. PubMed ID: 32253664 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study. Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175 [TBL] [Abstract][Full Text] [Related]
14. Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide. Blanchard-Rohner G Front Immunol; 2021; 12():711637. PubMed ID: 34408752 [TBL] [Abstract][Full Text] [Related]
15. Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. Halasa NB; Gerber MA; Berry AA; Anderson EL; Winokur P; Keyserling H; Eckard AR; Hill H; Wolff MC; McNeal MM; Edwards KM; Bernstein DI J Pediatric Infect Dis Soc; 2015 Sep; 4(3):214-24. PubMed ID: 26334249 [TBL] [Abstract][Full Text] [Related]
16. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. ; Shearer WT; Fleisher TA; Buckley RH; Ballas Z; Ballow M; Blaese RM; Bonilla FA; Conley ME; Cunningham-Rundles C; Filipovich AH; Fuleihan R; Gelfand EW; Hernandez-Trujillo V; Holland SM; Hong R; Lederman HM; Malech HL; Miles S; Notarangelo LD; Ochs HD; Orange JS; Puck JM; Routes JM; Stiehm ER; Sullivan K; Torgerson T; Winkelstein J J Allergy Clin Immunol; 2014 Apr; 133(4):961-6. PubMed ID: 24582311 [TBL] [Abstract][Full Text] [Related]
17. [Antiviral immunization of immunocompromised adults, literature review]. Duchet Niedziolka P; Launay O; Salmon Ceron D; Consigny PH; Ancelle T; Van der Vliet D; Lortholary O; Hanslik T; Rev Med Interne; 2008 Jul; 29(7):554-67. PubMed ID: 17942195 [TBL] [Abstract][Full Text] [Related]
18. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ; MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501 [TBL] [Abstract][Full Text] [Related]
19. Immunization of immunocompromised persons. Weber DJ; Rutala WA Immunol Allergy Clin North Am; 2003 Nov; 23(4):605-34, v-vi. PubMed ID: 14753383 [TBL] [Abstract][Full Text] [Related]
20. Vaccinations in patients with multiple sclerosis: review and recommendations. Nesbitt C; Rath L; Zhong M; Cheng AC; Butzkueven H; Wesselingh R; Skibina O; Monif M; Yeh W; Brotherton JM; Reddel S; Van Der Walt A Med J Aust; 2021 May; 214(8):350-354.e1. PubMed ID: 33866556 [No Abstract] [Full Text] [Related] [Next] [New Search]